Inaktiver Wert

Andere Sprachen Cadila Healthcare Limited NSE India S.E.

Aktien

INE010B01019

Schlusskurs NSE India S.E. Andere Börsenplätze
- ^INR	-

10.05.	Indischer Arzneimittelhersteller Cipla übertrifft dank starker US-Nachfrage die Gewinnschätzungen für das vierte Quartal	RE
09.05.	Zydus Lifesciences Limited gibt den Abschluss der Rekrutierung für die Phase 2B/3-Studie EPICS IIITM zur Bewertung von Saroglitazar Mg zur Behandlung der primären biliären Cholangitis bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets	13.05.
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	10.05.
Zydus Lifesciences Limited Announces Completion of Enrolment for EPICS IIITM Phase 2B/3 Trial Evaluating Saroglitazar Mg in Treatment of Primary Biliary Cholangitis	09.05.
Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel	09.05.
Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5%	09.05.
Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	06.05.
Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug	06.05.
Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19	29.04.
Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19	29.04.
Weak March Quarter Earnings Weigh Down Indian Equities on Friday	26.04.
Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream	26.04.
Zydus Lifesciences Limited Receives Final Approval from USFDA for Tretinoin Cream USP, 0.1%	26.04.
Zydus Lifesciences Limited Receives Demand Order-In-Original for the Financial Year 2018-19	25.04.
Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection	24.04.
China Medical System's Anti-Anaemia NDA Accepted in China	23.04.
Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator	23.04.
Zydus Lifesciences Limited Announces New Drug Application of Zydus' Innovative Drug Desidustat Tablets by China Medical System Holdings Limited Accepted in China	23.04.
Zydus launches Mirabegron Extended-Release Tablets in the US	22.04.
Zydus Lifesciences Limited Launches Mirabegron Extended-Release Tablets in the U.S	22.04.
Zydus Arm Get UK Drug Regulator's Marketing Approval for Nulibry as MoCD Type A Treatment	22.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cadila Healthcare Limited NSE India S.E.

Aktien

INE010B01019

Andere Sprachen

Filter